Rezultati - Hailiang Hu
- Showing 1 - 17 results of 17
-
1
MicroRNAs: new players in the DNA damage response od Hailiang Hu, Richard A. Gatti
Izdano 2010Revisão -
2
-
3
-
4
Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum od Liutao Du, Refik Kayalı, Carmen Bertoni, Francesca Fike, Hailiang Hu, Patrick L. Iversen, Richard A. Gatti
Izdano 2011Artigo -
5
-
6
-
7
-
8
-
9
-
10
-
11
Cyclin‐dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration‐resistant prostate cancer od Haozhe Zhang, Yi Zhou, Yating Feng, Wenli Hou, Yafei Chen, Zengzhen Xing, Yifan Zhang, Qiang Wei, Yu Yin, Ju Guo, Hailiang Hu
Izdano 2024Artigo -
12
A New Series of Small Molecular Weight Compounds Induce Read Through of All Three Types of Nonsense Mutations in the ATM Gene od Liutao Du, Michael E. Jung, Robert Damoiseaux, Gladys C. Completo, Francesca Fike, Jin‐Mo Ku, Shareef Nahas, Cijing Piao, Hailiang Hu, Richard A. Gatti
Izdano 2013Artigo -
13
N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway od Yu Yin, Lingfan Xu, Yan Chang, Tao Zeng, Xufeng Chen, Aifeng Wang, Jeff Groth, Wen‐Chi Foo, Chang Yin Liang, Hailiang Hu, Jiaoti Huang
Izdano 2019Artigo -
14
-
15
A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1 od Shuai Yuan, Shaohua He, Luyao Li, Shu Xi, Hong Weng, Jinhui Zhang, Danqi Wang, Guo Mengmeng, Haozhe Zhang, Shuang-Ying Wang, Dao‐Jing Ming, Meng-Yang Liu, Hailiang Hu, Xian‐Tao Zeng
Izdano 2023Artigo -
16
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer od Lingfan Xu, Yu Yin, Yanjing Li, Xufeng Chen, Yan Chang, Hong Zhang, Juan Liu, James Beasley, Patricia McCaw, Haoyue Zhang, Sarah P. Young, Jeff Groth, Qianben Wang, Jason W. Locasale, Xia Gao, Dean G. Tang, Xuesen Dong, Yiping He, Daniel J. George, Hailiang Hu, Jiaoti Huang
Izdano 2021Artigo -
17
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer od Yanjing Li, Yiping He, William Butler, Lingfan Xu, Yan Chang, Kefeng Lei, Hong Zhang, Yinglu Zhou, Allen C. Gao, Qingfu Zhang, Daniel Taylor, Donghui Cheng, Suzette Farber-Katz, Rachid Karam, Tyler Landrith, Bing Li, Sitao Wu, Vickie Hsuan, Qing Yang, Hailiang Hu, Xufeng Chen, Melissa Flowers, Shannon J. McCall, John K. Lee, B. Smith, Jung Wook Park, Andrew S. Goldstein, Owen N. Witte, Qianben Wang, Matthew B. Rettig, Andrew J. Armstrong, Qing Cheng, Jiaoti Huang
Izdano 2019Artigo
Iskalna orodja:
Sorodne teme
Biology
Cancer research
Gene
Genetics
Cancer
Cell biology
Medicine
Internal medicine
Cell
Prostate cancer
Biochemistry
DNA
DNA damage
Molecular biology
microRNA
Amino acid
DNA repair
Prostate
Androgen receptor
Cell cycle
Downregulation and upregulation
Embryonic stem cell
Glutaminase
Glutamine
Immunology
Missense mutation
Mutation
Nonsense mutation
Receptor
Signal transduction